MediBuddy Files for IPO Following $125 Million Series C Funding Round

MediBuddy is a leading digital healthcare platform in India, headquartered in Bengaluru, India. The company provides users with 24/7 one-stop healthcare services.

Recently, MediBuddy announced the completion of its $125 million Series C financing round. The round was led by Quadria Capital and Lightrock India, with participation from Bessemer Venture Partners, India Life Sciences Fund III, Rebright Partners, JAFCO Asia, TEEAM Fund LP, FinSight Ventures, InnoVen Capital, Stride Ventures, and Alteria Capital.

This funding round is regarded as one of the largest in the digital healthcare services sector, valuing the startup at $450 million post-financing.

In 2015, IIT Madras alumni Satish Kannan and Enbasekar Dinadayalane founded MediBuddy in Bengaluru, India, with a team of just six people. To date, MediBuddy has completed six funding rounds, raising a total of $192.1 million, and has grown into a leading digital healthcare platform with more than 1,500 employees.

In just eight years, how did MediBuddy grow from a six-person team into India’s leading digital healthcare platform, and how did it secure $120 million in major funding?

As early as the founding of MediBuddy, Satish Kannan and Enbasekar recognized that 70% of health issues could be consulted, diagnosed, and treated through remote online medical assistance, and that the digitalization of the healthcare industry could help people living in the most remote areas gain timely access to professional medical services.

MediBuddy was founded with the mission of enabling all 1.3 billion people in India to conveniently access high-quality healthcare services. However, a persistent and challenging issue has been the shortage of qualified and skilled medical professionals. To address this problem, MediBuddy embarked on the development of a comprehensive digital healthcare platform.

Enbasekar, Co-founder and Chief Technology Officer of MediBuddy, possesses extensive experience and expertise in the healthcare sector, particularly in the development of medical software, medical devices, and cutting-edge technologies for the healthcare industry. Leveraging his rich background in healthcare, MediBuddy has built a comprehensive healthcare platform that closely aligns with user needs and provides on-demand access to healthcare services.

MediBuddy offers virtually all healthcare services, enabling users to consult online, purchase medications, and schedule laboratory tests. Meanwhile,Users can access MediBuddy’s features through paid subscriptions without needing to purchase the website or app, thereby lowering the barrier to entry.

First, MediBuddy provides a communication channel for patients and experienced doctors through telemedicine, establishing 18 round-the-clock online consultation specialties, such as cardiology, neurology, dermatology, pediatrics, gynecology, psychiatry, orthopedics, general medicine, etc. Patients can pay lower consultation fees than offline consultations and communicate with doctors via video or voice calls regarding their conditions.

Online consultations with doctors are not only fast but also cost-effective. According to reports, consulting through MediBuddy can save up to 60% in costs, including consultation fees and travel expenses.

The platform has also launched the MediBuddy Gold service, which allows paid subscribers to receive unlimited free consultations for up to six family members.According to MediBuddy, the usage of its paid service, MediBuddy Gold, surged significantly during the outbreak of the COVID-19 pandemic.

Secondly, MediBuddy users can purchase medications and book laboratory tests from home through the platform, with MediBuddy responsible for delivering the medications to users.

Finally, in addition to online services, MediBuddy has also established physical MediBuddy clinics to provide offline consultations.

The company has established partnerships with multiple leading enterprises in India, whereby employer clients purchase its services, enabling their employees to access a range of healthcare benefits.

In recent years, the COVID-19 pandemic has overwhelmed India’s traditional healthcare infrastructure, and the vision of digitizing healthcare platforms is being realized at an unprecedented pace.

To date, MediBuddy has built a partner network comprising more than 90,000 doctors, 7,000 hospitals, 3,000 diagnostic centers, and 2,500 pharmacies. With over 1,000 team members across 22 cities in India, it has met the healthcare needs of 30 million Indians.Meeting the needs of over 35,000 people across India every day, a figure that surpasses any large brick-and-mortar hospital chain in the country.

In 2021, MediBuddy provided vaccination services to over 700 companies, supporting 15 million individuals—including employees and their families—with vaccination camps set up either at their offices or at all MediBuddy-partnered hospitals.

To this end, it has partnered with more than 350 top-tier hospitals across 130 cities, including Delhi, Chennai, Bengaluru, Indore, Jaipur, Lucknow, Noida, and Kochi. MediBuddy announced a partnership with the crowdfunding platform Milaap to raise funds and provide free physician consultations to individuals exhibiting COVID-19 symptoms, a move that further boosted MediBuddy’s brand visibility.

Satish Kannan, co-founder and CEO of MediBuddy, stated, “As alumni of IIT Madras, we are moving towards the goal of delivering high-quality healthcare to a population of 1.3 billion.” In recognition of their contributions to India’s healthcare industry, both Satish Kannan and Enbasekar were named to the Forbes 30 Under 30 list in Asia (2017) and India (2018).

MediBuddy Co-Founder Satish Kannan

MediBuddy Co-Founder Enbasekar D

Medi Assist, the parent company of MediBuddy, was established in September 1999 and is one of the earliest Third-Party Administrators (TPAs) in India to obtain licensing from the IRDAI (Insurance Regulatory and Development Authority of India). MediBuddy, as the technology platform of Medi Assist, was founded in 2000.

In 2011, Bessemer Venture Partners acquired a minority stake in Medi Assist. Together with Medi Assist’s management, Bessemer purchased the shares held by Reliance Health Ventures and injected new capital into the company, marking the beginning of MediBuddy’s growth journey.

By 2020, after years of refinement, MediBuddy had built an online platform integrating doctors, hospitals, healthcare providers, pharmaceutical companies, and insurance companies.

At that time, as the pandemic raged, India’s traditional healthcare system was struggling to function normally, with hospitals operating at full capacity and doctors overworked. Under these circumstances,Telemedicine and online consultation technologies, which help compensate for India’s fragmented public healthcare system, have emerged as a powerful force; in particular, the appeal of online doctor consultation companies surged during the lockdowns imposed by the government to curb the COVID-19 pandemic.

The “Telemedicine Practice Guidelines” issued by the Indian Ministry of Health and Family Welfare on March 25, 2020, further promoted the development of online doctor consultation services.

Not only MediBuddy, but also its India-based competitors—Lybrate, Practo, and Mfine—have experienced significant growth since 2020. Among them, Practo has completed seven funding rounds, raising a total of $228.2 million, and is currently transitioning from an online-only model to an online-plus-offline approach.

In June 2020, DocsApp, India’s largest online doctor consultation platform, co-founded by Enbasekar and Satish Kannan, merged with MediBuddy to establish market leadership and enhance services. The merged entity, MediBuddy, took a significant step forward toward becoming India’s largest online healthcare platform.

Perhaps the merger between DocsApp and MediBuddy sparked strong investor interest in MediBuddy; in February 2021, MediBuddy announced that it had completed a $40 million Series B financing round.

At this time, India’s telemedicine market is gaining momentum, presenting a vast market opportunity. As a pioneer among online healthcare platforms, MediBuddy has established a comprehensive platform to meet market demand and continuously introduces new services to attract new users.

As MediBuddy’s user base and traffic grew, coordinating with multiple payment platforms became an issue.To ensure the smoothest payment experience for users, MediBuddy has partnered with Razorpay, a third-party payment provider in India.This collaboration breaks down Indian users’ historical hesitation toward online consultations through mechanisms such as automated online billing and rapid refunds, thereby enhancing user trust in MediBuddy’s online services while introducing new payment mechanisms for MediBuddy’s offline channels (e.g., medical camps).

Satish Kannan stated, “Since partnering with Razorpay, MediBuddy has seen substantial month-on-month growth in both its user base and platform traffic. In the first six months following the collaboration, MediBuddy’s platform achieved a 16% increase in revenue, likely driven by the rewards and promotional campaigns introduced through Razorpay.”

MediBuddy's next step is to expand its influence in India, particularly in tier-2 and tier-3 cities., as early as the merger between DocsApp and MediBuddy, Kannan stated that 50% of MediBuddy’s customers came from tier-2 cities and smaller towns, with the remainder from tier-1 cities. As a country with a population of approximately 1.38 billion, India has a vast population in its tier-2 and tier-3 cities; this move represents a critical step toward achieving the goal of universal digital healthcare coverage.

Satish Kanan, Co-founder and CEO of MediBuddy, stated, “With the latest round of financing, we will launch new services on our platform. Leveraging our network of healthcare providers and our team, we will continue to lead the digital transformation of India’s healthcare industry.”